Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2026
Exchange: Nasdaq Capital Market
Event: Notice of non-compliance with Nasdaq minimum bid price requirements.
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. The document does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Listing Status: The Company received written notice from Nasdaq on May 8, 2026, stating it failed to meet the Minimum Bid Price Requirement of $1.00 per share for 30 consecutive business days.
- Compliance Period: The Company has been granted an initial 180-calendar day compliance period ending November 4, 2026, to regain compliance.
- Trading Status: The notice has no immediate effect; the common stock will continue to be listed and traded on the Nasdaq Capital Market during the compliance period.
Guidance, Outlook, and Risks
- Proposed Remedy: The Company has included a proposal for a reverse stock split in its Proxy Statement for the 2026 Annual Meeting of Stockholders. Management believes this action, if approved, would help regain compliance.
- Uncertainty: There is no assurance that the reverse stock split will be approved, that it will result in compliance, or that the Company will meet the $1.00 bid price requirement for ten consecutive business days within the grace period.
- Delisting Risk: If the Company fails to regain compliance by November 4, 2026, it may face delisting, though it may be eligible for additional time to reach compliance.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to various risks and uncertainties.
Investor Verification Checklist
- Verify the outcome of the 2026 Annual Meeting of Stockholders regarding the proposed reverse stock split.
- Monitor the daily closing bid price of RMTI common stock to track progress toward the $1.00 threshold.
- Review the Company's 2025 Annual Report (Form 10-K) for underlying financial performance and liquidity status not detailed in this 8-K.
- Watch for any subsequent 8-K filings regarding the status of the compliance period or potential delisting proceedings after November 4, 2026.